Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

53.3K
Overview
53.3K
Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Preparedness and Phobias01:09

Preparedness and Phobias

425
Human fear responses to certain stimuli, such as darkness, heights, deep water, and blood, can often arise despite the absence of direct negative experiences. This phenomenon is rooted in evolutionary psychology, which posits that humans have developed a predisposition to fear stimuli that historically posed significant survival threats. This predisposition, known as preparedness, suggests that early humans who developed a fear of potentially dangerous entities, such as venomous snakes and...
425
Development of Immunocompetence01:22

Development of Immunocompetence

1.1K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.7K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduced T cell epitope cross-conservation and immunogenic potential is associated with emergence of a dominant influenza subclade K in 2025.

Human vaccines & immunotherapeutics·2026
Same author

HLA Class II Alleles DRB1*11:01 and DQB1*03:01 Unmask Immunogenetic Susceptibility to Anti-Nivolumab Antibodies in Combination with Ipilimumab.

The AAPS journal·2026
Same author

Immunogenicity risk assessment of peptide-related impurities identified in generic teriparatide products.

Frontiers in immunology·2025
Same author

Establishment of Immune Biobank for Vaccine Immunogenicity Prediction Using In Vitro and In Silico Methods Against Porcine Reproductive and Respiratory Syndrome Virus.

Vaccines·2025
Same author

A method for identifying neoantigens through isolation of circulating tumor cells using apheresis among patients with advanced-stage cancer.

Frontiers in immunology·2025
Same author

T cell epitope content comparison using EpiCC correlates with vaccine efficacy against heterologous porcine reproductive and respiratory syndrome virus type 2 strains.

Frontiers in microbiology·2025

Related Experiment Video

Updated: Mar 18, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.3K

Agility in adversity: Vaccines on Demand.

Anne S De Groot1,2, Leonard Moise1,2, David Olive3

  • 1a EpiVax, Inc. , Providence , RI , USA.

Expert Review of Vaccines
|July 9, 2016
PubMed
Summary

The US lacks preparedness for biothreats like Ebola and Anthrax. However, advanced technologies can enable rapid vaccine development on demand, improving biodefense capabilities.

Keywords:
BLAFDAINDT cellT-cell assayVaccineZika virusanthraxavian influenzabiodefensebioterrorcancer vaccinecomputational vaccinologyepitope-driven vaccinegenomegenome-to-vaccineiVAX systemimmunoinformaticsinfluenzapandemicpersonalized vaccineplatformsmallpox

More Related Videos

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.7K
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

4.0K

Related Experiment Videos

Last Updated: Mar 18, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.3K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.7K
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

4.0K

Area of Science:

  • Biodefense and infectious disease preparedness
  • Vaccine technology and development
  • Genomic surveillance

Background:

  • The United States faces significant biodefense challenges from potential biological attacks using agents like Ebola and Anthrax, and emerging infectious diseases such as Zika.
  • Current biodefense strategies may be insufficient to address these evolving threats effectively.

Purpose of the Study:

  • To assess the US readiness for biological attacks and emerging infectious disease epidemics.
  • To explore the potential of advanced technologies for rapid vaccine development and biodefense enhancement.
  • To propose a strategy for designing effective biodefense vaccines utilizing real-time genomic data.

Main Methods:

  • Analysis of current US biodefense capabilities and challenges.
  • Evaluation of advancements in sequencing technology and computational power for vaccine development.
  • Leveraging insights from cancer research initiatives ('moonshot') for biodefense strategies.

Main Results:

  • The US is currently not adequately prepared for major biological threats.
  • Technological advancements, including 'vaccines on demand', are making rapid vaccine development feasible.
  • Flexible vaccine production platforms can complement or replace traditional stockpiles.

Conclusions:

  • The US can enhance its biodefense by adopting 'vaccines on demand' strategies.
  • Integrating real-time biosurveillance with advanced vaccine technologies is crucial for future preparedness.
  • Investment in flexible production platforms and genomic sequencing will improve response to biothreats.